These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14991846)

  • 1. Quantification of hemorphins in Alzheimer's disease brains.
    Poljak A; McLean CA; Sachdev P; Brodaty H; Smythe GA
    J Neurosci Res; 2004 Mar; 75(5):704-14. PubMed ID: 14991846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LVV- and VV-hemorphins: comparative levels in rat tissues.
    Yatskin ON; Philippova MM; Blishchenko EYu ; Karelin AA; Ivanov VT
    FEBS Lett; 1998 May; 428(3):286-90. PubMed ID: 9654150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro degradation of the human hemorphin LVV-H7 in mammalian plasma analysed by capillary zone electrophoresis and mass spectrometry.
    John H; Schulz S; Forssmann WG
    Biopharm Drug Dispos; 2007 Mar; 28(2):73-85. PubMed ID: 17173283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid peptides derived from hemoglobin: hemorphins.
    Zhao Q; Garreau I; Sannier F; Piot JM
    Biopolymers; 1997; 43(2):75-98. PubMed ID: 9216245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric identification and quantification of hemorphins extracted from human adrenal and pheochromocytoma tissue.
    Cerpa-Poljak A; Lahnstein J; Mason KE; Smythe GA; Duncan MW
    J Neurochem; 1997 Apr; 68(4):1712-9. PubMed ID: 9084445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
    Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
    Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological and quantatitive capillary changes in aging human brain].
    Wang LN; Xu D; Gui QP; Zhu MW; Zhang HH; Hu YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):104-7. PubMed ID: 15171542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.
    Gelfanova V; Higgs RE; Dean RA; Holtzman DM; Farlow MR; Siemers ER; Boodhoo A; Qian YW; He X; Jin Z; Fisher DL; Cox KL; Hale JE
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):149-58. PubMed ID: 17584762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Toropygin IY; Kugaevskaya EV; Mirgorodskaya OA; Elisseeva YE; Kozmin YP; Popov IA; Nikolaev EN; Makarov AA; Kozin SA
    Rapid Commun Mass Spectrom; 2008; 22(2):231-9. PubMed ID: 18085519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
    Shiozaki K; Iseki E
    J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain processing of hemorphin-7 peptides in various subcellular fractions from rats.
    Murillo L; Piot JM; Coitoux C; Fruitier-Arnaudin I
    Peptides; 2006 Dec; 27(12):3331-40. PubMed ID: 17097762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7.
    Fruitier I; Garreau I; Piot JM
    Biochem Biophys Res Commun; 1998 May; 246(3):719-24. PubMed ID: 9618278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.
    Mazurek MF; Beal MF; Bird ED; Martin JB
    Ann Neurol; 1986 Dec; 20(6):665-70. PubMed ID: 3813496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies on aminopeptidase M-mediated degradation of human hemorphin LVV-H7 and its N-terminally truncated products.
    John H; John S; Forssmann WG
    J Pept Sci; 2008 Jul; 14(7):797-803. PubMed ID: 18236385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.
    Rezaie P; Pontikis CC; Hudson L; Cairns NJ; Lantos PL
    J Histochem Cytochem; 2005 Aug; 53(8):929-40. PubMed ID: 16055747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
    van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.